Low morbidity but prolonged viral shedding characterize parainfluenza virus 3 infections in allogeneic peripheral stem cell transplant recipients.

被引:2
|
作者
Aliyu, ZY
Bordner, MA
Henderson, DK
Sloand, EM
Young, NS
Childs, R
Bennett, J
Barrett, J
机构
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] NIH, Warren Grant Magnuson Clin Ctr, Off Director, Bethesda, MD 20892 USA
[3] NIAID, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V104.11.2234.2234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2234
引用
收藏
页码:614A / 614A
页数:1
相关论文
共 50 条
  • [31] Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review
    Shah, Dimpy P.
    Shah, Pankil K.
    Azzi, Jacques M.
    Chemaly, Roy F.
    CANCER LETTERS, 2016, 370 (02) : 358 - 364
  • [32] Failure of ribavirin in the treatment of adenovirus infections in hematopoietic stem cell transplant (HSCT) recipients.
    Howard, DS
    Harper, RM
    Phillips, GL
    Reece, DE
    Martin, C
    Rayens, MK
    Pomeroy, C
    BLOOD, 2001, 98 (11) : 393A - 393A
  • [33] Usefulness of an Immunodeficiency Scoring Index for predicting outcomes of respiratory virus infections in allogeneic stem cell transplant recipients
    Wang, L.
    Allen, J.
    Diong, C.
    Goh, Y. -T.
    Gopalakrishnan, S.
    Ho, A.
    Hwang, W.
    Lim, F.
    Tan, T. -T.
    Tan, B. -H.
    Linn, Y. -C.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S392 - S393
  • [34] EFFECTIVE USE OF ORAL RIBAVIRIN FOR RESPIRATORY SYNCYTIAL VIRAL INFECTIONS IN ADULT ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Gorcea, C. M.
    Tholouli, E.
    Turner, A.
    Davies, E.
    Battersby, E.
    Saif, M.
    Dignan, F.
    HAEMATOLOGICA, 2016, 101 : 634 - 634
  • [35] Prolonged Outbreak of Adenovirus A31 Among Allogeneic Stem Cell Transplant Recipients
    Swartling, L. P.
    Allard, A.
    Torlen, J.
    Ljungman, P.
    Mattsson, J.
    Sparrelid, E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S77 - S77
  • [36] Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation
    J Casey
    K Morris
    M Narayana
    M Nakagaki
    G A Kennedy
    Bone Marrow Transplantation, 2013, 48 : 1558 - 1561
  • [37] Hepatitis B virus vaccination of recipients and donors of allogeneic peripheral blood stem cell transplantation: Risk and benefit ratio of HBV vaccination in recipients.
    Idilman, R
    Ustun, C
    Akan, H
    Karayalcin, S
    Ozcan, M
    Arslan, O
    Ilhan, O
    Akyol, G
    Bozdayi, M
    Colantoni, A
    Van Thiel, DH
    Kok, H
    HEPATOLOGY, 2000, 32 (04) : 455A - 455A
  • [38] Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation
    Casey, J.
    Morris, K.
    Narayana, M.
    Nakagaki, M.
    Kennedy, G. A.
    BONE MARROW TRANSPLANTATION, 2013, 48 (12) : 1558 - 1561
  • [39] T cells for viral infections after allogeneic hematopoietic stem cell transplant
    Bollard, Catherine M.
    Heslop, Helen E.
    BLOOD, 2016, 127 (26) : 3331 - 3340
  • [40] Detection of cytomegalovirus specific cytotoxic T lymphocyte in allogeneic hematopoietic stem cell transplant recipients.
    Sun, J
    Huang, T
    Yi, ZS
    Liu, QF
    Xu, D
    Ye, CX
    Meng, FY
    BLOOD, 2005, 106 (11) : 421B - 421B